Literature DB >> 11459841

Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle.

E L McDearmon1, A C Combs, J M Ervasti.   

Abstract

We present evidence for the expression of three alpha-dystroglycan glycoforms in skeletal muscle cells, including two minor glycoforms marked by either patent or latent reactivity with the N-acetylgalactosamine-specific lectin Vicia villosa agglutinin. Both minor glycoforms co-isolated with beta-dystroglycan, but not with other dystrophin/utrophin-glycoprotein complex components, suggesting that they may perform distinct or modified cellular functions. We also confirmed that both patent and latent V. villosa agglutinin-reactive alpha-dystroglycan glycoforms are expressed in C2C12 myotubes. However, we found that the combined effect of saturating concentrations of V. villosa agglutinin and laminin-1 were strictly additive with respect to acetylcholine receptor cluster formation in C2C12 myotubes, which suggests that laminin-1 and V. villosa agglutinin do not compete for the same binding site on the cell surface. Finally, although beta-N-acetylhexosaminidase digestion dramatically inhibited agrin-, V. villosa agglutinin-, and laminin-1-induced acetylcholine receptor clustering in C2C12 myotubes, treatment with this enzyme had no effect on the amount of alpha-dystroglycan that was bound to V. villosa agglutinin-agarose. We conclude that alpha-dystroglycan is not the V. villosa agglutinin receptor implicated in acetylcholine receptor cluster formation. However, our data provide new support for the hypothesis that different glycoforms of alpha-dystroglycan may perform distinct functions even within the same cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459841     DOI: 10.1074/jbc.M103843200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation.

Authors:  Ariana C Combs; James M Ervasti
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

2.  Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx.

Authors:  Brian J McMorran; Francis E McCarthy; Elizabeth M Gibbs; Mabel Pang; Jamie L Marshall; Alison V Nairn; Kelley W Moremen; Rachelle H Crosbie-Watson; Linda G Baum
Journal:  Glycobiology       Date:  2016-05-28       Impact factor: 4.313

3.  Formation of multiple complexes between beta-dystroglycan and dystrophin family products.

Authors:  M Royuela; D Chazalette; G Hugon; R Paniagua; V Guerlavais; J A Fehrentz; J Martinez; J P Labbe; F Rivier; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

4.  Mutational and functional analysis of Large in a novel CHO glycosylation mutant.

Authors:  Jennifer T Aguilan; Subha Sundaram; Edward Nieves; Pamela Stanley
Journal:  Glycobiology       Date:  2009-05-21       Impact factor: 4.313

Review 5.  Muscular dystrophies due to glycosylation defects.

Authors:  Francesco Muntoni; Silvia Torelli; Martin Brockington
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

6.  Induction of myasthenia by immunization against muscle-specific kinase.

Authors:  Kazuhiro Shigemoto; Sachiho Kubo; Naoki Maruyama; Naohito Hato; Hiroyuki Yamada; Chen Jie; Naoto Kobayashi; Katsumi Mominoki; Yasuhito Abe; Norifumi Ueda; Seiji Matsuda
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

7.  A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.

Authors:  Cecilia Jimenez-Mallebrera; Silvia Torelli; Lucy Feng; Jihee Kim; Caroline Godfrey; Emma Clement; Rachael Mein; Stephen Abbs; Susan C Brown; Kevin P Campbell; Stephan Kröger; Beril Talim; Haluk Topaloglu; Ros Quinlivan; Helen Roper; Anne M Childs; Maria Kinali; Caroline A Sewry; Francesco Muntoni
Journal:  Brain Pathol       Date:  2008-08-07       Impact factor: 6.508

8.  Diversity of the Brain Dystrophin-Glycoprotein Complex.

Authors:  Kevin Culligan; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2002

9.  ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.

Authors:  Sebahattin Cirak; Aileen Reghan Foley; Ralf Herrmann; Tobias Willer; Shu Yau; Elizabeth Stevens; Silvia Torelli; Lina Brodd; Alisa Kamynina; Petr Vondracek; Helen Roper; Cheryl Longman; Rudolf Korinthenberg; Gianni Marrosu; Peter Nürnberg; Daniel E Michele; Vincent Plagnol; Matt Hurles; Steven A Moore; Caroline A Sewry; Kevin P Campbell; Thomas Voit; Francesco Muntoni
Journal:  Brain       Date:  2013-01-03       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.